Smart Drug Delivery Systems Global Market is Projected to Increase Revenues Growth, Business Insights, Future Demand and Forecast 2024-2033 | Pfizer Inc., Bayer AG, Medtronic plc, Amgen Inc., Novo Nordisk

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Smart Drug Delivery Systems Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $25.94 Bn In 2028 At A CAGR Of 19.7% :

The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $10.61 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 19.2%. The growth in the historic period can be attributed to increasing demand for drug delivery systems, rising patient compliance, rising prevalence of chronic diseases, increasing personalized medicine, and need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $25.94 billion in 2028 at a compound annual growth rate (CAGR) of 19.7%. The growth in the forecast period can be attributed to growing burden of non-communicable diseases, increased focus on precision medicine, the rise of theragnostic, growing demand for non-invasive drug delivery methods, and increasing healthcare expenditure. Major trends in the forecast period include miniaturization and microfabrication technologies, advancements in material science, integration of artificial intelligence (AI) and machine learning (ML), development of nano-sized drug delivery systems, and integration of IoT and wearable technology.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp

Smart Drug Delivery Systems Market Major Segments
The smart drug delivery systems market covered in this report is segmented -
1) By Product: Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-On Sensors, Other Products
2) By Therapeutic Area: Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Other Therapeutic Areas
3) By Drug Delivery Mode: Injectable, Inhalation, Oral
4) By End-User: Hospitals, Clinics, Home Care, Ambulatory Care Settings, Other End-Users

Key Driver - Impact Of Rising Chronic Diseases On Smart Drug Delivery Systems Market

The rising prevalence of chronic diseases is expected to propel the growth of the smart drug delivery systems market going forward. Chronic diseases are long-term health conditions that progress slowly over time and often have complex causes. The prevalence of chronic diseases is increasing due to aging populations, environmental influences, and disparities in healthcare access. Smart drug delivery systems offer a promising approach to managing chronic diseases by enhancing medication effectiveness and increasing patient adherence. For instance, in January 2023, according to the National Library of Medicine, the US-based medical library, by 2050, there will be 142.66 million people with at least one chronic illness, a 99.5% rise from 71.522 million in 2020. Therefore, the rising prevalence of chronic diseases is driving the smart drug delivery systems market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=14796&type=smp

Prominent Trend - Advanced Technologies In Smart Drug Delivery Systems

Major companies operating in the smart drug delivery systems market focus on developing reusable drug delivery devices, such as Qfinity, to revolutionize drug administration. Qfinity is a reusable drug delivery device used to administer medication, unlike single-use devices that are disposed of after one use. For instance, in May 2022, Jabil Inc., a US-based manufacturing services company, launched Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of drugs. The device is capable of handling over 100 injections per device, accommodating 1 mL or 2.25 mL pre-filled cartridges and offering a 60% reduction in carbon footprint per injection. The Qfinity autoinjector platform is versatile, featuring broad technical specifications for drug volumes and viscosities. Additionally, a connected version called Qfinity+ allows for remote monitoring of patients' care and compliance through built-in sensors and electronics, providing connectivity without compromising ease of use.

Smart Drug Delivery Systems Market Players
Major companies operating in the smart drug delivery systems market are Pfizer Inc, Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc, Boston Scientific Corporation, Biogen Inc, Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the smart drug delivery systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Smart Drug Delivery Systems Market Report Structure
3. Smart Drug Delivery Systems Market Trends And Strategies
4. Smart Drug Delivery Systems Market - Macro Economic Scenario
5. Smart Drug Delivery Systems Market Size And Growth
…..
27. Smart Drug Delivery Systems Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.